EUDRAC is a European specialised regulatory affairs and pharmacovigilance consultancy company providing support to our clients to drive products through development, registration, market launch and post-approval activities across all EU countries.
EUDRAC is based in Germany, France and the UK, since 2002.
About usEUDRAC Ltd is extremely proud to have won a 2018 Queen’s Award for Enterprise in the International Trade category.
The Queen’s Awards for Enterprise are the UK’s most prestigious business awards, recognising and celebrating business excellence across the UK
Our customised packages aim to meet the needs requirements of both small and large healthcare companies. We have become valued and integral members of our clients’ project teams.
This has lead to a high level of repeat business and ongoing long–term assignments with our clients and is proof of the excellent service EUDRAC provides.
Contact us below to help you to achieve your goals!
ContactGuidance is Relevant to DCP/MRP/National Marketing Authorisations CMDh has issued an updated Questions and Answers document regarding Brexit for how...
Read moreDIA 2019 Vienna EUDRAC will be exhibiting at the annual DIA Europe Meeting in Vienna, Austria from 5th - 7th February 2019. Our team would be pleased...
Read moreNew MHRA Guidance following a ‘hard’ Brexit On January 3rd the MHRA issued its updated guidance on the regulation of medicines, medical devices and...
Read more